All News

While family planning clinics are hailing the FDA's recent approval of mifepristone (RU-486) as a noninvasive way to terminate an unwanted pregnancy, ob/gyns who decide to administer the drug need to familiarize themselves with the research on its advantages and disadvantages.

Many obstetric malpractice cases focus on fixing the blame for disturbed neurological function in the first days of an infant's life. Results of recent case-control studies, described here by the authors, question the traditional thinking that most of the risk factors are in the intrapartum period.

Gives criteria for evaluating and diagnosing bleeding disorders in newborns and tells how to differentiate such disorders in newborns, children, and adults.

Malpractice

Forceps injuries cases, failed tubal ligation, amniotic fluid embolism.

Updates

news items for December

Latest research on infertility, breast cancer, and other subjects, from the 2000 Annual Conference of ASRM

AltmedWatch

the latest research on complementary and alternative medicine

AltmedWatch

the latest research on complementary and alternative medicine

Inside this Issue: President's Letter Editor's Corner ISGE Training Report Update on Women’s Healthcare in Nepal An Homage to János Veres Laparoscopic Creation of a Neo-Vagina Interview with Dr. Yap Lip Kee Interview with Dr. Chuck Miller